P-80 TRYbeCA-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma

Authors :: M. Noel
Antonio Cubillo
R. Berardi
Richard Kay
Nigel Biswas-Baldwin
Richard Greil
Teresa Macarulla
S. Kacel
Pascal Hammel
Harpreet Wasan
E. Van Cutsem
Peter Nygren
G.J.M. Creemers
L. Grummer
Manuel Hidalgo
Christos Fountzilas
J.-P. Metges
Hagop Youssoufian
Anu Gupta
Pia Österlund
Thomas Seufferlein
Iman El-Hariry
Source :: Annals of Oncology. 31:S115
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
0303 health sciences
medicine.medical_specialty
Chemotherapy
Second line treatment
business.industry
medicine.medical_treatment
Phases of clinical research
Hematology
medicine.disease
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
medicine
Adenocarcinoma
In patient
business
030304 developmental biology

Full Text Access

Tools